NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

You ironically say two contradictory things at once.

1) The street and BP partners see "serious issues with this management team", implying no deal is likely, very bad, bad, bad.
2) There's a plan to sweep the exiting team aside and put in a new C suite and board, and that is why they have not had a CFO. Now it's planned. Planned with whom? Sounds like it is planned with a BP.
3) Then back again to the no CFO is bottom feeder style management.

The post is filled with contradictions. I can see how getting the price down before a buyout would be helpful to the bottom lines of some, but it's just right out there. No subtlety.